BTMD - biote Corp. News

B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $1.5

B. Riley Securities analyst Jeff Van Sinderen maintains Biote (NASDAQ:BTMD) with a Neutral and lo

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday'

biote Corp. (BTMD) Q2 2026 Earnings Call Transcript

biote Corp. (BTMD) Reports Break-Even Earnings for Q2

biote Corp. (BTMD) reported break-even quarterly earnings per share versus the Zacks Consensus Estim

marketbeat.com

biote Q2 Earnings Call Highlights

biote NASDAQ: BTMD reported lower second-quarter revenue and a net loss as a voluntary recall of cer

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday&

Biote Q2 EPS $(0.23) Misses $0.04 Estimate, Sales $44.232M Miss $46.148M Estimate

Biote (NASDAQ:BTMD) reported quarterly losses of $(0.23) per share which missed the analyst consensu

Biote Reports Second Quarter 2026 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization an

Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in i

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

IRVING, Texas--(BUSINESS WIRE)--Biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) today announce

gurufocus.com

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

[url="]Biote[/url] (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging sol

Biote Reaffirms FY26 Guidance For Revenue Above $190M And Adjusted EBITDA Above $38M

Biote reaffirmed its full year 2026 guidance for revenue above $190 million, Adjusted EBITDA above $

Biote Appoints CFO And Chief Business Officer Bob Peterson As Interim CEO And Director, Effective Ju

Biote (NASDAQ:BTMD), a leader in innovative hormone optimization and healthy aging solutions that ad

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization an

biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates

biote Corp. (BTMD) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus

Biote Q1 2026 Earnings Call: Complete Transcript

Earnings Scheduled For May 6, 2026

Biote Q1 EPS $0.06 Beats $0.03 Estimate, Sales $44.935M Miss $46.023M Estimate

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.06 per share which beat the analyst consensus

Biote Reports First Quarter 2026 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization an

Biote Schedules First Quarter 2026 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in i

Truist Securities Maintains Buy on Biote, Lowers Price Target to $4

Truist Securities analyst Gregory Fraser maintains Biote (NASDAQ:BTMD) with a Buy and lowers the

B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $2

B. Riley Securities analyst Jeff Van Sinderen maintains Biote (NASDAQ:BTMD) with a Neutral and lo

biote Corp. (BTMD) Q4 2025 Earnings Call Transcript

biote Corp. (BTMD) Q4 Earnings and Revenues Top Estimates

biote Corp. (BTMD) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus

Biote Q4 EPS $0.06 Beats $0.05 Estimate, Sales $46.408M Beat $46.190M Estimate

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.06 per share which beat the analyst consensus

Biote Reports Fourth Quarter and Full Year 2025 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization an

Earnings Scheduled For March 11, 2026

Earnings Outlook For Biote

Biote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading inn

Biote Expects $1.3M Charge For Q4 Due To Recall Of Specific Lots Of Hormone Pellets; Additional Reca

On January 26, 2026, F.H. Investments, Inc. ("Asteria Health"), a 503B manufacturer of compo

defenseworld.net

Head to Head Comparison: Agilent Technologies (NYSE:A) vs. biote (NASDAQ:BTMD)

biote (NASDAQ: BTMD - Get Free Report) and Agilent Technologies (NYSE: A - Get Free Report) are both

defenseworld.net

biote Corp. $BTMD Stock Position Lessened by Bandera Partners LLC

Bandera Partners LLC decreased its position in shares of biote Corp. (NASDAQ: BTMD) by 6.2% in the s

biote Corp. (BTMD) Q3 2025 Earnings Call Transcript

biote Corp. ( BTMD ) Q3 2025 Earnings Call November 5, 2025 5:00 PM EST Company Participants Bret Ch

biote Corp. (BTMD) Tops Q3 Earnings and Revenue Estimates

biote Corp. (BTMD) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus

Biote Affirms FY2025 Sales Guidance of $190.000M vs $192.670M Est

Biote (NASDAQ:BTMD) affirms FY2025 sales outlook from $190.000 million to $190.000 million vs $192.6

Biote Q3 EPS $0.22 Beats $0.07 Estimate, Sales $47.956M Beat $47.757M Estimate

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.22 per share which beat the analyst consensus

Earnings Scheduled For November 5, 2025

B. Riley Securities Downgrades Biote to Neutral, Lowers Price Target to $4

B. Riley Securities analyst Jeff Van Sinderen downgrades Biote (NASDAQ:BTMD) from Buy to Neutral

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Biote Lowers FY2025 Sales Guidance from $202.000M-$208.000M to $190.000M vs $204.667M Est

Biote (NASDAQ:BTMD) lowers FY2025 sales outlook from $202.000 million-$208.000 million to $190.000 m

Biote Q2 EPS $0.10 Beats $0.06 Estimate, Sales $48.90M Miss $49.52M Estimate

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.10 per share which beat the analyst consensus

Earnings Scheduled For August 6, 2025

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

Biote Affirms FY2025 Sales Guidance of $202.00M-$208.00M vs $205.31M Est

Biote (NASDAQ:BTMD) affirms FY2025 sales outlook from $202.00 million-$208.00 million to $202.00 mil

Biote Q1 EPS $0.37 Beats $0.07 Estimate, Sales $48.99M Beat $46.99M Estimate

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.37 per share which beat the analyst consensus

Earnings Scheduled For May 7, 2025

Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket